| Cimetidine | A histamine H2 receptor antagonist used to manage GERD, peptic ulcer disease, and indigestion. |
| Abemaciclib | A medication used to treat HR+ HER2- advanced or metastatic breast cancer. |
| Brigatinib | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. |
| Rucaparib | An anti-cancer agent used to treat recurrent ovarian, fallopian tube, or peritoneal cancer. |
| Bictegravir | An integrase inhibitor used to treat HIV infections. |
| Lofexidine | A centrally acting alpha2-adrenergic agonist used for the symptomatic treatment of acute opioid withdrawal syndrome to facilitate abrupt opioid discontinuation in adults. |
| Plazomicin | An aminoglycoside antibiotic used to treat complicated urinary tract infections. |
| Tafenoquine | An antiparasitic agent used for the treatment and prevention of relapse of Vivax malaria. |
| Levofloxacin | A fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria of the upper respiratory tract, skin and skin structures, urinary tract, and prostate, as well as for post-exposure treatment of inhaled anthrax and the plague. |
| Ciprofloxacin | A second generation fluoroquinolone used to treat various susceptible bacterial infections. |
| Topotecan | An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. |
| Pyrimethamine | An antiparasitic drug used in the prevention and treatment of toxoplasmosis and malaria. |
| Rifamycin | An antibacterial used to treat traveler's diarrhea. |
| Gilteritinib | An AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia. |
| Glasdegib | A sonic hedgehog receptor inhibitor used to treat newly diagnosed acute myeloid leukemia in patients over 75 years who cannot receive intense chemotherapy. |
| Pexidartinib | An antitumor agent that is used for the treatment of rare disease tenosynovial giant cell tumors (TGCT) by inhibiting colony-stimulating factor 1 and its receptor. |
| Fedratinib | Fedratinib is indicated to treat adults with primary or secondary myelofibrosis that is either intermediate-2 or high risk. |
| Istradefylline | A selective adenoside A2A receptor antagonist indicated in adjunct to levodopa and carbidopa for the treatment of Parkinson's Disease. |
| Flecainide | A class Ic antiarrhythmic agent used to manage atrial fibrillation and paroxysmal supraventricular tachycardias (PSVT). |
| Apalutamide | An androgen receptor inhibitor used to treat non metastatic, castration resistant prostate cancer. |
| Lasmiditan | An oral 5HT1F agonist used for the acute treatment of migraine headache with or without aura. |
| Verapamil | A non-dihydropyridine calcium channel blocker used in the treatment of angina, arrhythmia, and hypertension. |
| Famotidine | A histamine H2 receptor antagonist used to treat duodenal ulcers, benign gastric ulcers, GERD, and Zollinger-Ellison syndrome. |
| Guanfacine | An alpha-2A adrenergic receptor agonist used to treat ADHD. |
| Tazemetostat | A methyltransferase inhibitor indicated to treat patients 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. |
| Trimethoprim | An antifolate antibiotic often used in combination with sulfamethoxazole to treat a number of infections, including those of the urinary tract, respiratory tract, and gastrointestinal tract. |
| Ranolazine | An anti-anginal drug used for the treatment of chronic angina. |
| Rimegepant | An oral CGRP receptor antagonist used for the acute treatment of migraines with or without aura in adults. |
| Osilodrostat | An oral inhibitor of cortisol synthesis used to treat Cushing's disease by normalizing hypercortisolism. |
| Methylene blue | An oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia. |
| Tucatinib | A kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer. |
| Pemigatinib | A kinase inhibitor used to treat locally advanced or metastatic, unresectable cholangiocarcinoma in previously treated adult patients. |
| Capmatinib | A kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping. |
| Selpercatinib | A RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations. |
| Ripretinib | A kinase inhibitor used to treat advanced gastrointestinal stromal tumor (GIST). |
| Risdiplam | An oral mRNA splicing modifier used in the treatment of spinal muscular atrophy (SMA). |
| Pralsetinib | A RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer. |
| Remdesivir | A nucleoside analog used to treat RNA virus infections including COVID-19. |
| Tirbanibulin | A tyrosine kinase and tubulin inhibitor used to treat actinic keratosis on the face or scalp. |
| Trilaciclib | A CDK4 and CDK6 inhibitor to reduce the risk of chemotherapy induced myelosuppression. |